Rivaroxaban and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is reported as a side effect among people who take Rivaroxaban (rivaroxaban), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lansoprazole, and have Short-bowel syndrome.

The phase IV clinical study analyzes which people have Pancreatitis when taking Rivaroxaban. It is created by eHealthMe based on reports of 26,430 people who have side effects when taking Rivaroxaban from the FDA, and is updated regularly.

What is Rivaroxaban?

Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 1,762 drugs and 2,027 conditions by eHealthMe. Check the latest studies of Pancreatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

26,430 people reported to have side effects when taking Rivaroxaban.
Among them, 58 people (0.22%) have Pancreatitis.

Among these 58 people:

How long have people been on Rivaroxaban when they have Pancreatitis? *

What is the gender of people who have Pancreatitis when taking Rivaroxaban? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Pancreatitis when taking Rivaroxaban? *

What are other drugs people take besides Rivaroxaban? *

What are other side effects people have besides Pancreatitis? *

Abdominal Pain: 18 people, 31.03%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 18 people, 31.03%
Abdominal Discomfort: 12 people, 20.69%
Dehydration (dryness resulting from the removal of water): 12 people, 20.69%
Weight Decreased: 12 people, 20.69%
Panic Disorder: 11 people, 18.97%
Poor Quality Sleep: 11 people, 18.97%
Choledocholithiasis (stones in the common bile duct): 11 people, 18.97%
Pain: 11 people, 18.97%
Weight Increased: 11 people, 18.97%

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 11 people, 18.97%
Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 7 people, 12.07%
Staphylococcal Infection (an infection with staphylococcus bacteria): 7 people, 12.07%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 12.07%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 10.34%
Gastric Cancer (stomach cancer): 4 people, 6.90%
High Blood Cholesterol: 4 people, 6.90%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 5.17%
Infection: 3 people, 5.17%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Rivaroxaban and have Pancreatitis?

- Check whether Pancreatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivaroxaban:

Rivaroxaban (26,544 reports)

Pancreatitis treatments and more:

Pancreatitis (62,704 reports)

Browse all side effects of Rivaroxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis:

Pancreatitis (1,762 drugs)

Browse all the conditions that are associated with Pancreatitis:

Pancreatitis (2,027 conditions)

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Rivaroxaban) and Rivaroxaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.